-
Nov 15, 2024 | 
detroitnews.com | Daniel Gilbert |Rachel Roubein |David Ovalle
Pharmaceutical industry representatives in Washington are scrambling to measure the damage Robert F. Kennedy Jr. might inflict on one of his favorite targets, the Food and Drug Administration, if he is confirmed as secretary of health and human services. By proposing Kennedy, the political family scion whose controversial statements on vaccines have unnerved industry and public health officials, President-elect Donald Trump signaled that he favors disruption of the medical establishment.
-
Jul 3, 2024 | 
calgarysun.com | Rachel Roubein |Daniel Gilbert
Kisunla, the brand name for donanemab, is one of the few treatments developed for Alzheimer's that modifies the underlying disease • You can save this article by registering for free here. Or sign-in if you have an account. Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission from purchases made through links on this page.
-
Jul 2, 2024 | 
sunjournal.com | Rachel Roubein |Daniel Gilbert
show_chartPersonalised advertising, advertising and content measurement, audience research and services developmentdevicesStore and/or access information on a deviceYou can choose how your personal data is used.
-
Jul 2, 2024 | 
pressherald.com | Rachel Roubein |Daniel Gilbert
The Food and Drug Administration on Tuesday granted approval to a closely watched Alzheimer’s drug, concluding that the benefits of modestly slowing progression of the devastating disease outweigh its risks, drugmaker Eli Lilly announced. The agency, in a surprise move in March, had delayed approval of the drug, known as donanemab, to further scrutinize the drug’s safety and effectiveness.
-
Mar 22, 2024 | 
finans.dk | Daniel Gilbert
22/03/2024 KL. 15:00 For abonnenter Medicare plans can cover the popular weight-loss drug Wegovy to treat seniors with a history of cardiovascular disease, officials said Thursday, a move that could substantially expand access to the blockbuster drug for certain adults. Until now, seniors participating in federal prescription-drug programs could not be covered Log ind Få adgang til FINANS - Overblik, inspiration og indsigt i dansk og internationalt erhvervsliv.
-
Mar 1, 2024 | 
adn.com | Daniel Gilbert
Walgreens and CVS said Friday that they are preparing to dispense the abortion pill mifepristone in states where it is legally allowed, starting as soon as next week. Walgreens said it has completed the Food and Drug Administration’s certification process to sell mifepristone and expects to do so within a week. “We are beginning a phase rollout in select locations to ensure quality, safety and privacy for our patients, providers and team members,” the company said.
-
Dec 26, 2023 | 
torontosun.com | Daniel Gilbert
Skip to ContentAdvertisement 1 Trending Trending Trending • • Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission from purchases made through links on this page. Article contentFederal health authorities are intensifying their scrutiny of the drug ketamine for treating mental health disorders, as the mind-altering compound grows in popularity despite the lack of regulatory approval for such use.
-
Dec 5, 2023 | 
pressherald.com | Aaron Gregg |Daniel Gilbert
CVS Health is planning a companywide overhaul of how it prices prescription drugs, doing away with the complex and often opaque formulas that typically govern what patients pay for medications. Under a new system announced Tuesday, which it calls CostVantage, CVS said it will price drugs based on cost, a set markup, and a fee to cover pharmacy services.
-
Aug 30, 2023 | 
finans.dk | Amy Goldstein |Daniel Gilbert
30/08/2023 KL. 10:00 For abonnenter The Biden administration Tuesday identified 10 expensive prescription drugs it has chosen for price negotiations with pharmaceutical manufacturers as the government seeks to ease the financial burden on older and disabled Americans.
-
Jun 12, 2023 | 
adn.com | Daniel Gilbert
The letters from the insurance company arrived in recent weeks, bearing a warning to health care providers who prescribe Ozempic, a diabetes drug that has gained popularity as a weight-loss treatment. “The Special Investigations Unit has completed a comprehensive review of your prescription and professional claims,” said one letter to a Missouri doctor from insurer Anthem Blue Cross Blue Shield.
